Renue Life Sciences
Renue Life Sciences reported $250,000 raised in an SEC Form D filed on 2026-10-14. State of the filing: California.
- Industry
- Biotechnology
- Location
- California
About
Renue Life Sciences appears in Section 3 of the Raise Track Update of 2026-10-15, which lists new SEC Form D filings. The filing reports $250,000 raised and gives California as the state. The industry on the filing is Biotechnology. Related persons named on the filing: Samuel Perli (executive officer, director, promoter, San Carlos, California); Phanidhar Kukutla (executive officer, director, promoter, San Carlos, California); Jean-Louis Lelogeais (director, San Carlos, California). Filing: https://www.sec.gov/Archives/edgar/data/2158207/000215820726000001/0002158207-26-000001-index.htm
This page is not indexed by search engines yet. A Form D on its own does not name investors or a round type, so the page is promoted once a second source confirms the raise.
Funding history
| Round | Date | Amount | Lead |
|---|---|---|---|
| Form D 2026 | 2026-10-14 | $250K |
Sources
Last verified:
- https://www.sec.gov/Archives/edgar/data/2158207/000215820726000001/0002158207-26-000001-index.htm
Type: sec filing. Accessed 2026-10-15.
SEC Form D for Renue Life Sciences, Inc. EDGAR filing date 2026-10-14. Signed 2026-10-13. First sale 2026-10-02. Total amount sold $250,000 of an offering amount of $3,000,000. 8 investors already invested. Issuer address city is San Carlos, California. Jurisdiction of incorporation is Delaware. The form does not name those investors or a round type. Street addresses are not published. The form gives a related person's name as Samuel David Perli. The page uses Samuel Perli. - https://buttondown.com/raisetrack/archive/raise-track-update-2026-10-15/
Type: other verified public source. Accessed 2026-10-15.
Raise Track Update for 2026-10-15, Section 3 (SEC Form D filings). Lists Renue Life Sciences, state CALIFORNIA, industry Biotechnology, amount raised $250,000.